首页|儿童抗N-甲基-D-天冬氨酸受体脑炎继发癫痫的相关影响因素分析

儿童抗N-甲基-D-天冬氨酸受体脑炎继发癫痫的相关影响因素分析

扫码查看
目 的 目前抗 N-甲基-D-天冬氨酸受体(N-methyl-D-aspartate receptor,NMDAR)脑炎患儿恢复期继发癫痫的风险低,相关研究较少,大部分临床医生对其认识不足。对继发癫痫和非继发癫痫的抗NMDAR脑炎患儿进行对比研究,以提高临床医生对抗NMDAR脑炎及其继发癫痫的临床特征及相关影响因素的认识。方 法 回顾性分析 2015年 1月至 2022年 1月就诊于武汉儿童医院神经内科的 50例确诊抗NMDAR脑炎患儿的临床资料,根据最后随访时患儿是否继发癫痫分为脑炎后癫痫组(PE组)和脑炎后非继发癫痫组(NO-PE组),采用泊松回归分析进行统计。结 果 脑炎后癫痫发生率为 8%(4/50)。50例患儿男女比为 0。61∶1,继发癫痫患儿男女比是 1∶3。抗NMDAR脑炎临床症状表现多样,最常见临床症状之一的癫痫发作占 86%(43/50),其中以癫痫发作为起病的占 64%(32/50)。继发癫痫患儿中有 75%(3/4)也是以癫痫发作作为首发症状,同时更容易遗留运动障碍(50%(2/4))和学习能力下降(75%(3/4))。治疗上,大部分脑炎患儿给予免疫治疗,急性期有 74%(37/50)给予抗癫痫药物治疗。PE组头颅影像学示皮质下受累(75%(3/4)比 13%(6/46))、累及基底节区(50%(2/4)比 0(0/46))及脑电图提示存在 δ刷(50%(2/4)比 8。7%(4/46))与 NO-PE组比较差异均有统计学意义(P<0。05)。结 论 抗NMDAR脑炎患儿临床症状表现多样,继发癫痫发生率低,进展为脑炎后癫痫,若及时添加抗癫痫药物可控制发作;头颅影像学示皮质下受累、基底节区受累及脑电图提示存在δ刷的患儿更易继发癫痫。
Related Influencing Factors Analysis of Epilepsy Secondary to Anti-N-methyl-D-aspartate Receptor Encephalitis in Children
Objective The current low risk of secondary epilepsy in children recovering from N-methyl-D-aspartate receptor(NMDAR)resistant encephalitis is poorly studied and under-recognized by most clinicians.A comparative study of children with anti-NMDAR encephalitis secondary to epilepsy and non-secondary to epilepsy was conducted to improve clinicians′ understanding of the clinical features and associated factors influencing anti-NMDAR encephalitis and its secondary epilepsy.Methods A retrospective analysis was conducted on the clinical data of 50 children with confirmed anti-NMDAR encephalitis who visited the neurology department of Wuhan Children′s Hospital from January 2015 to January 2022.Based on whether the children had secondary epilepsy at the final follow-up,they were divided into the post-encephalitis epilepsy group(PE group)and the post-encephalitis non-secondary epilepsy group(NO-PE group).Poisson regression analysis was used for statistics.Results The incidence of post-encephalitis epilepsy was 8%(4/50).The male-to-female ratio of 50 children was 0.61∶1.The male-to-female ratio of children with secondary epilepsy was 1∶3.The clinical manifestations of anti-NMDAR encephalitis were diverse,with epilepsy being one of the most common clinical symptoms,accounting for 86%(43/50),of which 64%(32/50)were initiated by epilepsy.Among children with secondary epilepsy,75%(3/4)also had seizures as the first symptom and were more likely to have motor disorders left(50%(2/4))and decreased learning ability left(75%(3/4)).In terms of treatment,most children with encephalitis received immunotherapy,and 74%(37/50)of them were treated with antiepileptic drugs in the acute phase.The head imaging showed there was a statistically significant difference(P<0.05)between the PE group and the NO-PE group in subcortical involvement(75%(3/4)vs.13%(6/46)),involvement of the basal ganglia area(50%(2/4)vs.0%(0/46)),and electroencephalography showing the presence δ brush(50%(2/4))vs.(8.7%(4/46)).Conclusion The clinical symptoms of children with anti-NMDAR encephalitis are diverse,and the incidence of secondary epilepsy is low.Antiepileptic drugs can promptly control seizures after progression to post-encephalitis epilepsy,the children with head imaging showing subcortical involvement,basal ganglia area,and electroencephalogram suggesting the presence δ brush are more likely to develop secondary epilepsy.

autoimmune encephalitispostencephalitic epilepsychildren

齐乐、孙丹

展开 >

江汉大学 医学部,湖北 武汉 430056

武汉儿童医院 神经内科,湖北 武汉 430016

自身免疫性脑炎 脑炎后癫痫 儿童

2024

江汉大学学报(自然科学版)
江汉大学

江汉大学学报(自然科学版)

影响因子:0.413
ISSN:1673-0143
年,卷(期):2024.52(6)